All charts and data below are CPI-U inflation-adjusted and with dividends reinvested. (Why?)
RVMD real return snapshot: after CPI-U inflation, RVMD returned +316.71% over the past year and +143.14% YTD, with dividends reinvested. Since Feb. 13, 2020, RVMD is up +434.11% in real purchasing-power return, or +28.66%/yr, and is currently â9.51% below its real total-return high on Aug. 27, 2026.
Data ending Wed Oct. 7, 2026
| Thu 2020-02-13đŹ to Wed 2026-10-07 |
Overall
Return |
Exponential
Trendline |
||||
|---|---|---|---|---|---|---|
| RVMD × |
+434.11%
+28.66%/yr |
+16.41%/yr
R2=0.290 |
||||
| Revolution Medicines Inc NASDAQ Common Stock | ||||||
| Thu 2020-02-13đŹ to Wed 2026-10-07 |
Start
Value |
End
Value |
|---|---|---|
| RVMD × |
$10,000.00
2020-02-13 |
$53,411.26
2026-10-07 |
| YTD | YoY | |
|---|---|---|
| RVMD × | +143.14% | +316.71% |
|
Current
Drawdown |
Worst
Drawdown |
|
|---|---|---|
| RVMD × |
â9.51%
on 2026-10-07 from 2026-08-27 peak |
â75.90%
on 2022-05-12 from 2021-02-08 peak |
| Period ending Wed 2026-10-07 | 1 yr | 2 yr | 3 yr | 5 yr | 10 yr |
|---|---|---|---|---|---|
| RVMD × | +316.71% |
+298.14% +99.53%/yr |
+634.54% +94.39%/yr |
+489.73% +42.60%/yr |
— |
| Year | RVMD |
|---|---|
| 2026 (YTD) | +143.14% |
| 2025 | +77.36% |
| 2024 | +48.24% |
| 2023 | +16.50% |
| 2022 | â11.11% |
| 2021 | â40.60% |
| 2020 | +35.84% |